6 Combat HIV/AIDS, malaria and other diseases
Where we are
Target 7A: Have Halted by 2015 and Begun to Reverse the Spread of HIV/AIDS
Target 7B: By 2010, Universal Access to Treatment for HIV/AIDS for all those Who Need It
Target 8: Have Halted by 2015 and Begun to Reverse the Incidence of Malaria and other Major Diseases
HIV/AIDS incidence is low in Armenia, and the HIV/AIDS epidemic is in the concentrated stage occurring mostly among the maximum-risk populations. Nevertheless, assessments of the HIV/AIDS situation show that the estimated number of people living with HIV in the country is around 2,300.
Since 1999, continuous improvements in the malaria situation have been recorded, and since 2006 there were no local malaria cases registered in Armenia. Armenia is one of the first countries in the European region where malaria has been practically eliminated.
In 2008, the tuberculosis incidence per 100,000 was 46 up from 24.9 in 1995 (the estimated TB incidence is much higher due to the fact that not all TB patients are registered properly).
chieving the targets stated under MDG 6 by 2015 is a challenge for policy makers and issues related to HIV/AIDS, tuberculosis, malaria and other socially important infectious diseases are a priority.
The 8 Millennium Development Goals
- 1 Eradicate extreme hunger and poverty
- 2 Achieve universal primary education
- 3 Promote gender equality and empower women
- 4 Reduce child mortality
- 5 Improve maternal health
- 6 Combat HIV/AIDS, malaria and other diseases
- 7 Ensure environmental sustainability
- 8 Develop a global partnership for development
Targets for MDG6
- Halt and begin to reverse the spread of HIV/AIDS
- HIV prevalence among population aged 15-24 years
- Condom use at last high-risk sex
- Proportion of population aged 15-24 years with comprehensive correct knowledge of HIV/AIDS
- Ratio of school attendance of orphans to school attendance of non-orphans aged 10-14 years
- Achieve, by 2010, universal access to treatment for HIV/AIDS for all those who need it
- Proportion of population with advanced HIV infection with access to antiretroviral drugs